Cargando…

Reduced HIV symptoms and improved health-related quality of life correlate with better access to care for HIV-1 infected women: the ELLA study

INTRODUCTION: Global HIV-1 prevalence is 35.3 million [1]; women comprise >50% of those infected. The majority of women may lack regular care and only one-fourth are virologically suppressed [2]. ELLA is a cross-sectional, non-interventional study conducted across Europe, Latin America, Canada an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baran, Robert, Mulcahy, Fiona, Krznaric, Ivanka, d'Arminio Monforte, Antonella, Samarina, Anna, Xi, He, Cassetti, Isabel, Valdez Madruga, Jose, Zachry, Woodie, van Wyk, Jean, Martinez, Marisol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International AIDS Society 2014
Materias:	Poster Sessions – Abstract P084
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224867/ https://www.ncbi.nlm.nih.gov/pubmed/25394120 http://dx.doi.org/10.7448/IAS.17.4.19616

Ejemplares similares

Development of a multi-component risk assessment process for face to face consultations in an outpatient setting
por: Drake, C., et al.
Publicado: (2022)

Viro-immunological characterization of naïve patients with high cerebrospinal fluid (CSF) HIV RNA
por: Iannuzzi, Francesca, et al.
Publicado: (2014)

Barriers to access to care reported by women living with HIV across 27 countries
por: Johnson, Margaret, et al.
Publicado: (2015)

INQUÉRITO POPUPACIONAL: PREVALÊNCIA DE INFECÇÃO POR SARS‐COV‐2 EM ADULTOS NO MUNICÍPIO DE SÃO CARLOS
por: Zenatti, Carolina Toniolo, et al.
Publicado: (2021)

STATUS EPILEPTICUS ASSOCIADO A ENCEFALITE POR COVID-19
por: Rabelo, Barbara Lenoir, et al.
Publicado: (2022)

NEUROCRIPTOCOCOSE PÓS-COVID COM EVOLUÇÃO POUCO COMUM EM PACIENTE APARENTEMENTE IMUNOCOMPETENTE: RELATO DE CASO
por: Fernandes, Herbert José, et al.
Publicado: (2022)

Factors associated with HPV-DNA clearance in a cohort of HIV-positive patients: role of cART and gender
por: Suardi, Elisa, et al.
Publicado: (2014)

Association between abdominal aortic calcifications, bone mineral density and vertebral fractures in a cohort of HIV-positive patients
por: Iannotti, Nathalie, et al.
Publicado: (2014)

Atazanavir/ritonavir monotherapy as maintenance strategy in HIV-1 treated subjects with viral suppression: 96-week analysis results of the MODAT study
por: Spagnuolo, Vincenzo, et al.
Publicado: (2014)

Increased risk of virological failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: data from the ICONA cohort
por: Saracino, Annalisa, et al.
Publicado: (2014)

Determinants of use of the fixed dose combination emtricitabine/rilpivirine/tenofovir (Eviplera) in HIV-infected persons receiving care in Italy
por: Cozzi-Lepri, Alessandro, et al.
Publicado: (2014)

Treatment discontinuation in HIV-1-infected individuals starting their first-line HAART after 2008: data from the ICONA Foundation Study Cohort
por: Di Biagio, Antonio, et al.
Publicado: (2014)

Safety analysis of raltegravir/truvada regimen in HIV/HCV co-infected patients without switchback after HCV treatment
por: Ehret, Robert, et al.
Publicado: (2014)

Co-administration of ritonavir-boosted protease inhibitors and rate of tenofovir discontinuation in clinical practice
por: Costarelli, Silvia, et al.
Publicado: (2014)

Acute hepatitis C virus (HCV) infection in the setting of HIV coinfection: a single-centre 10-year follow-up
por: Ingiliz, Patrick, et al.
Publicado: (2014)

Increased incidence of sexually transmitted diseases in the recent years: data from the ICONA cohort
por: Cingolani, Antonella, et al.
Publicado: (2014)

Evolution of Framingham cardiovascular risk score in HIV-infected patients initiating EFV- and LPV/r-based HAART in a Latin American cohort
por: Cecchini, Diego, et al.
Publicado: (2014)

Durability of lopinavir/ritonavir dual-therapies in individuals with viral load <50 copies/mL in the observational setting
por: Gianotti, Nicola, et al.
Publicado: (2014)

Do Combination Antiretroviral Therapy Regimens for HIV Infection Feature Diverse T-Cell Phenotypes and Inflammatory Profiles?
por: Tincati, Camilla, et al.
Publicado: (2020)

Is weak CD4+ gain in the course of suppressive combination antiretroviral therapy for HIV infection a current clinical challenge? A case report and brief review of the literature
por: Tincati, Camilla, et al.
Publicado: (2018)

Caring for women living with HIV: gaps in the evidence
por: Loutfy, Mona R, et al.
Publicado: (2013)

HIV-Infected Late Presenter Patients
por: D'Arminio Monforte, Antonella, et al.
Publicado: (2012)

Illness Representations of HIV Positive Patients Are Associated with Virologic Success
por: Leone, Daniela, et al.
Publicado: (2016)

Predictors of emphysema progression in HIV-positive patients
por: Guaraldi, Giovanni, et al.
Publicado: (2014)

Role of In Vitro Stimulation with Lipopolysaccharide on T-Cell Activation in HIV-Infected Antiretroviral-Treated Patients
por: Tincati, Camilla, et al.
Publicado: (2012)

Outcomes related to 4864 pregnancies with exposure to lopinavir/ritonavir (LPV/r)
por: Tookey, Pat, et al.
Publicado: (2014)

Management of Chronic Hepatitis B in HIV-Coinfected Patients
por: Fasano, Massimo, et al.
Publicado: (2022)

Determinants of HIV outpatient service utilization according to HIV parameters
por: Di Carlo, Paola, et al.
Publicado: (2014)

Transmission route and reasons for HIV testing among recently diagnosed HIV patients in HIV-TR cohort, 2011–2012
por: Dokuzoguz, Basak, et al.
Publicado: (2014)

Evidence for Polymicrobic Flora Translocating in Peripheral Blood of HIV-Infected Patients with Poor Immune Response to Antiretroviral Therapy
por: Merlini, Esther, et al.
Publicado: (2011)

Predictors of lack of serological response to syphilis treatment in HIV-infected subjects
por: Spagnuolo, Vincenzo, et al.
Publicado: (2014)

Loss to follow-up of HIV-infected women after delivery: The Swiss HIV Cohort Study and the Swiss Mother and Child HIV Cohort Study
por: Aebi-Popp, Karoline, et al.
Publicado: (2014)

Switch to raltegravir-based regimens and HIV DNA decrease in patients with suppressed HIV RNA
por: Bianco, Claudia, et al.
Publicado: (2014)

Invariant Natural Killer T (iNKT) Cells in HAART-Treated, HIV-Positive Patients with Bone and Cardiovascular Impairment
por: Tincati, Camilla, et al.
Publicado: (2014)

Effect of HIV infection-related factors on SVR rate in HCV treatment in HIV-infected patients
por: Kravchenko, Alexey, et al.
Publicado: (2014)

1557. The Real-World Impact of Pre-Exposure Prophylaxis (PrEP) Prescription Uptake and Dispensing Status on HIV Infection Risk in the US
por: Tao, Li, et al.
Publicado: (2023)

Recreational drugs and HIV in Europe: current use of recreational drugs and principal HIV guidelines related recommendations
por: Garin Escriva, Noe, et al.
Publicado: (2014)

The suspected unexpected and serious adverse events of antiretroviral drugs used as HIV prophylaxis in HIV uninfected persons
por: Pietraszkiewicz, Ewa, et al.
Publicado: (2014)

Liver Fibrosis progression using Fibroscan in HIV/HCV coinfected patients with undetectable HIV viral load
por: Perez-Martinez, Laura, et al.
Publicado: (2014)

Six-month immune responses to mRNA-1273 vaccine in combination antiretroviral therapy treated late presenter people with HIV according to previous SARS-CoV-2 infection
por: Augello, Matteo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_anl8n8nvn88a3otil6emdam0qt